Aurora BioScience to distribute IsoRay products in New Zealand, Australia

06/26/2013 | (free registration)

IsoRay Medical said it has selected Aurora BioScience as the distributor of its cesium-131 isotope line in Australia and New Zealand. The products use the cesium-131 isotope to treat various cancers, including prostate cancer, brain cancer, head and neck cancer, lung cancer and gynecologic cancers.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care